Cargando…
Data Sharing, Clinical Trials, and Biomarkers in Precision Oncology: Challenges, Opportunities, and Programs at the Department of Veterans Affairs
Cancer genomic research reveals that a similar cancer clinical phenotype (e.g., non‐small cell lung cancer) can arise from various mutations in tumor DNA. Thus, organ of origin is not a definitive classification. Further, targeted therapy for cancer patients (precision oncology) capitalizes on knowl...
Autores principales: | Fiore, LD, Brophy, MT, Ferguson, RE, Shannon, C, Turek, SJ, Pierce‐Murray, K, Ajjarapu, S, Huang, GD, Lee, CSE, Lavori, PW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414893/ https://www.ncbi.nlm.nih.gov/pubmed/28182272 http://dx.doi.org/10.1002/cpt.660 |
Ejemplares similares
-
The Veterans Affairs Precision Oncology Data Repository, a Clinical, Genomic, and Imaging Research Database
por: Elbers, Danne C., et al.
Publicado: (2020) -
The VA Point-of-Care Precision Oncology Program: Balancing Access with Rapid Learning in Molecular Cancer Medicine
por: Fiore, Louis D., et al.
Publicado: (2016) -
1882. Tuberculosis in the Department of Veterans Affairs: Missed Opportunities for Prevention
por: Oda, Gina, et al.
Publicado: (2019) -
Outcomes of Veterans Treated in Veterans Affairs Hospitals vs Non–Veterans Affairs Hospitals
por: Yoon, Jean, et al.
Publicado: (2023) -
Medical oncologists’ perspectives of the Veterans Affairs National Precision Oncology Program
por: Vashistha, Vishal, et al.
Publicado: (2020)